Median S100B concentrations at day 2 after intervention were lower in patients with favorable outcome ( mRS score 0 - 1 ) at 90 days compared to patients with unfavorable outcome ( mRS score 2 - 6 ) ( median 0.10 microg/L [ interquartile range 0.07 - 0.14 ] vs 0.20 microg/L [ 0.11 - 0.48 ] , p < 0.001 ) .